Coagulation, inflammation, and pregnancy complications

Lancet

Volumn 363, Issue 9403, 2004, Pages 96-97

  Sarig, Galit ^a   Brenner, Benjamin ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; BLOOD CLOTTING; CHROMOSOME TRANSLOCATION; ENDOCRINE DISEASE; FETUS MEMBRANE; FETUS WASTAGE; FIBRIN DEPOSITION; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; MAST CELL; NATURAL KILLER CELL; NOTE; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; SIGNAL TRANSDUCTION; SPONTANEOUS ABORTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; THROMBOPHILIA; THROMBOSIS; TROPHOBLAST; UTERUS MALFORMATION;

EID: 0347948548     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15309-3     Document Type: Note

References (14)

1. Stirling Y., Woolf L., North W.R.S., Seghatchian M.J., Meade T.W. Haemostasis in normal pregnancy. Thromb Haemost. 52:1984;176-182.
2. Szekeres-Bartho J., Faust Z., Varga P., Szereday L., Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol. 35:1996;348-351.
3. Bremme K. Haemostasis in normal pregnancy. Brenner B., Marder V.J., Conard J. Women's issues in thrombosis and hemostasis. 2002;151-165 Martin Dunitz, London.
4. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today. 14:1993;353-356.
5. Laird S.M., Tuckerman E.M., Cork B.A., Linjawi S., Blakemore A.I.F., Li T.C. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update. 9:2003;163-174.
6. Clifford K., Rai R., Watson H., Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 9:1994;1328-1332.
7. Hatasaka H.H. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol. 37:1994;625-634.
8. Sarig G., Younis J.S., Hoffman R., Lanir N., Blumenfeld Z., Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 77:2002;342-347.
9. Brenner B., Hoffman R., Blumenfeld Z., Weiner Z., Younis J.S. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost. 83:2000;693-697.
10. Laude I., Rongieres-Bertrand C., Boyer-Neumann C., et al. Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost. 85:2001;18-21.
11. Rai R., Regan L., Chitolie A., Donald J., Cohen H. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol. 103:1996;842-844.
12. Gris J.C., Quere I., Monpeyroux F., et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal-loss and no thrombotic antecedent - the Nimes Obstetricians and Haematologists Study 5 (NOHA5). Thromb Haemost. 81:1999;891-899.
13. Makhseed M., Raghupathy R., Azizieh F., Farhat R., Hassan N., Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod. 15:2000;2011-2017.
14. Marjono A.B., Brown D.A., Horton K.E., Wallace E.M., Breit S.N., Manuelpillai U. Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. Placenta. 24:2003;100-106.